historical perspectives on the treatment of mrcc
Published 6 years ago • 80 plays • Length 2:35Download video MP4
Download video MP3
Similar videos
-
4:16
treatment landscape of advanced clear cell rcc
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
1:10
dr. motzer on first-line treatment of metastatic rcc
-
6:56
role of tkis in intermediate or poor-risk mrcc
-
8:43
optimizing the upfront treatment of metastatic renal cell carcinoma
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
4:32
kidney cancer experts discuss surgical treatment
-
10:24
the typical prognosis of aggressive renal cell cancer
-
4:18
mrcc: how an approved i-o regimen impacts treatment
-
1:24
dr. mcdermott on the use of anti–pd-1 combinations in mrcc
-
2:09
comparing afami-cel with existing treatments in synovial sarcoma
-
7:31
conclusion: optimizing the treatment of renal cell carcinoma
-
26:34
latest developments in the treatment of mrcc
-
7:22
introduction and frontline treatment of renal cell carcinoma
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
4:39
evolving treatment landscape of renal cell carcinoma
-
0:51
dr. pal on the frontline approval of nivolumab and ipilimumab in mrcc
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
1:03
dr. mcgregor on the evolving treatment landscape of rcc
-
7:15
introduction: multidisciplinary frontline treatment of metastatic renal cell carcinoma
-
1:17
dr. figlin on the evolving treatment landscape of renal cell carcinoma
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc